Latest News about MRK
Recent news which mentions MRK
Merck's Blockbuster Cancer Drug Keytruda Secures FDA Approval For Biliary Tract Cancer
November 01, 2023
Tickers
MRK
From Benzinga
From Motley Fool
Jim Cramer Says Hold Onto This Tech Stock, But 'You're Not Going To Make A Lot Of Money In It Right Now, Because That Was A Really Terrible Last Quarter'
October 31, 2023
From Benzinga
2 No-Brainer AI Stocks to Buy and One to Run Away From
October 31, 2023
From InvestorPlace
Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week
October 30, 2023
From Benzinga
3 Deeply Undervalued Growth Stocks
October 27, 2023
From InvestorPlace
Why Pharma Giant Merck's Shares Are Shooting Higher Today
October 26, 2023
From Benzinga
Nasdaq Futures Plunge As Meta Warns Of Q4 Softness: GDP Data, Amazon Earnings On Investors' Radar Amid Market Mayhem
October 26, 2023
From Benzinga
Merck third-quarter results beat estimates, boosted by cancer drug and vaccine growth
October 26, 2023
From MarketWatch
Futures point to Nasdaq sliding further into correction territory as Meta shares retreat
October 26, 2023
From MarketWatch
Amazon, Alphabet, Meta, Intel Q3 Earnings This Week: Will Mega-Caps Shatter Forecasts And Revive Market?
October 23, 2023
From Benzinga
3 Safe Dividend Stocks to Beat Inflation
October 21, 2023
From Motley Fool
Investor Risk Sentiment Wavers Amid War, Interest Rate Concerns; Tesla Earnings Disappoint: The Week In The Markets
October 20, 2023
From Benzinga
Merck Signs Multi-Billion Deal With Japan's Daiichi Sankyo For Cancer Therapy Drug Development
October 20, 2023
From Benzinga
7 Healthcare Stocks to invest in for a Healthy Future
October 20, 2023
From InvestorPlace
Tickers
MRK
From MarketWatch
FDA Approves Merck's Top Selling Drug, Keytruda For Expanded Use In Lung Cancer Indication
October 17, 2023
From Benzinga
Tickers
MRK
From InvestorPlace
7 Safe Stocks to Steady Your Portfolio in 2024
October 15, 2023
From InvestorPlace
Merck's Lead Cancer Drug Meets Primary Goal In Certain Type Of Lung Cancer Patients
October 10, 2023
Tickers
MRK
From Benzinga
From Benzinga
Merck reports positive results for blockbuster cancer drug in treating non-small cell lung cancer
October 10, 2023
From MarketWatch
From InvestorPlace
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.